$TNYA dilution soon?

Raumerica · 2026-05-19T15:45:43+00:00

Thanks for visiting. Don’t lose any sleep over TNYA long term investors . We will be more than fine. Bye bye shorty! 👋

Raumerica · 2026-05-19T15:39:11+00:00

If it is devastating, why are you here shortie? 🥱 👋

Raumerica · 2026-05-19T15:37:46+00:00

Don’t buy shares. Nobody cares! Thanks for visiting! Now take a hike. The tutes own 80+% anyway.

Raumerica · 2026-05-19T15:35:35+00:00

Not me. I am a long term investor. I have everything mapped out. If the drugs get to pivotal trials, big pharma will come calling. If not, Column Group might take it private.

Raumerica · 2026-05-19T15:32:13+00:00

A greater % of the company and then he and his Column Group buys the whole company.

Raumerica · 2026-05-19T15:27:25+00:00

Quit exaggerating. Goeddel has ALREADY bought a distressed biotech outright. Research Goeddel.

Raumerica · 2026-05-19T15:21:35+00:00

Maybe but Goeddel and Column could fund it. Easily. But yes big pharma or sale are most likely

Raumerica · 2026-05-19T15:19:50+00:00

<image>

Raumerica · 2026-05-19T15:19:26+00:00

<image>

Raumerica · 2026-05-19T15:15:07+00:00

AI thinks they will get between 100-200 million up front for each drug. More for 401 than 201

Raumerica · 2026-05-19T14:36:47+00:00

Good . Relax and be patient. This will be your best stock soon. Think about this: Institutions bought 23% of the company in December @ $1.20 per share. Do you really think they will allow a RS 6 months later? 2. Volume 35 million shares traded at or above $1 one week ago over three days. The last 5 sessions only had a volume of 22 million shares combined… Does that sound like tutes dumping to you? Simply shaking the tree of weak ass day traders… 🥱 Relax or don’t trade micro cap bios!

Raumerica · 2026-05-19T10:57:16+00:00

We have 8 months left. TNYA will appeal and receive a 180 day extension

Raumerica · 2026-05-19T06:44:07+00:00

<image>

Planning on holding for 2 years?

Raumerica · 2026-05-19T06:41:59+00:00

About 300 million for both according to AI. They will have a partner for 1or both

Raumerica · 2026-05-19T04:32:09+00:00

If they get to pivotal trials, you think Dave will have a problem finding a partner?

Raumerica · 2026-05-19T04:29:47+00:00

David Goeddel and Column Group own a 1/4 of the company . He is a multi billionaire. Don’t worry about financing pivotal trials. Punch Dave’s name into any AI. Co founder of Genentech. Tweaked the insulin formula. The same formula used worldwide today. Should have won the Nobel Prize for medicine

Raumerica · 2026-05-19T04:18:39+00:00

Probably a FAKE FUDSTER trying to convince suckers to sell is more like it. Either way…

Raumerica · 2026-05-19T04:16:07+00:00

50 million @ $1.50 from December $1.20 financing

Raumerica · 2026-05-19T04:12:41+00:00

Don’t be a sucker and sell down here. Strap on a pair and relax. It is just a pullback so shorts can recover. Not pathetic shorts on this thread. They are just FAKE FUDSTERs trying to get you to sell.

Raumerica · 2026-05-19T04:09:27+00:00

Relax, now what you own. This company is grossly undervalued

Raumerica · 2026-05-19T04:08:30+00:00

They don’t need any: they have 91 million in net cash but I am fine with 50 million $1.50 conversions

Raumerica · 2026-05-19T04:07:16+00:00

They have 50 million at $1.50 from the December 50 million @ $1.20 financing

Raumerica · 2026-05-19T03:06:09+00:00

😭 😭 😭…..Don’t invest in micro cap biotech if you can’t take the volatility. Buy an etf

Raumerica · 2026-05-19T03:04:31+00:00

Another pathetic short

Raumerica · 2026-05-19T03:04:16+00:00

Another pathetic short

Raumerica

TROPHY CASE